Advertisement
Screener

Clearmind Medicine Inc. (CMND) Form 6-K: Report of foreign private issuer, 2022

Clearmind Medicine Inc. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-12-29: Form 6-K; Period of report 2022-12-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170979-6k_clearmind.htm.
  • 2022-12-28: Form 6-K; Period of report 2022-12-28; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170928-6k_clearmind.htm.
  • 2022-12-21: Form 6-K; Period of report 2022-12-21; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170596-6k_clearmind.htm.
  • 2022-12-15: Form 6-K; Period of report 2022-12-15; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170253-6k_clearmind.htm.
FiledFormPeriod of reportDescriptionDocument
2022-12-296-K2022-12-29REPORT OF FOREIGN PRIVATE ISSUERea170979-6k_clearmind.htm
2022-12-286-K2022-12-28REPORT OF FOREIGN PRIVATE ISSUERea170928-6k_clearmind.htm
2022-12-216-K2022-12-21REPORT OF FOREIGN PRIVATE ISSUERea170596-6k_clearmind.htm
2022-12-156-K2022-12-15REPORT OF FOREIGN PRIVATE ISSUERea170253-6k_clearmind.htm
2022-12-136-K2022-12-13REPORT OF FOREIGN PRIVATE ISSUERea170096-6k_clearmind.htm
2022-12-096-K2022-12-09REPORT OF FOREIGN PRIVATE ISSUERea169920-6k_clearmind.htm
2022-12-016-K2022-12-01REPORT OF FOREIGN PRIVATE ISSUERea169516-6k_clearmind.htm
2022-11-236-K2022-11-23REPORT OF FOREIGN PRIVATE ISSUERea169202-6k_clearmind.htm